Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes
Author:
Funder
zhejiang provincial natural science foundation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference36 articles.
1. Diabetes and cancer: a comprehensive review;Abudawood;J Res Med Sci,2019
2. The effects of Tai Chi on type 2 diabetes mellitus: a meta-analysis;Chao;J Diabetes Res,2018
3. A network meta-analysis for efficacy and safety of seven regimens in the treatment of type II diabetes;Wang;Biomed Pharmacother,2017
4. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses;Bellou;PLoS One,2018
5. Defining disease progression and drug durability in type 2 diabetes mellitus;Kalra;Eur Endocrinol,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin;Cureus;2024-04-12
2. Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine;The Journal of Clinical Endocrinology & Metabolism;2024-02-27
3. A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin;Diabetes Therapy;2023-11-14
4. Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study;Diabetes & Metabolism;2023-07
5. Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis;Expert Opinion on Drug Safety;2023-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3